DiagnaMed Boosts CERVAI™ AI With $150K IP Funding

DiagnaMed Holdings Corp. (TSE:DMED) has released an update.

DiagnaMed Holdings Corp., a digital healthcare AI company, has secured up to $150,000 in non-dilutive funding to bolster the intellectual property rights for its innovative CERVAI™ Brain Health AI solution. The funding comes from participating in Intellectual Property Ontario and the National Research Council of Canada Industrial Research Assistance Program’s IP Assist program. This financial support aims to aid the commercialization of CERVAI™, a cutting-edge tool designed to assess brain health and provide early warnings for cognitive decline.

For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.